Form 8-K - Current report:
SEC Accession No. 0001641172-25-000642
Filing Date
2025-03-25
Accepted
2025-03-25 17:27:48
Documents
18
Period of Report
2025-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49005
2 ex1-1.htm EX-1.1 309055
3 ex4-1.htm EX-4.1 121543
4 ex5-1.htm EX-5.1 15793
5 ex99-1.htm EX-99.1 12846
6 ex5-1_001.jpg GRAPHIC 11947
  Complete submission text file 0001641172-25-000642.txt   806471

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE gnlx-20250325.xsd EX-101.SCH 3012
8 XBRL LABEL FILE gnlx-20250325_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE gnlx-20250325_pre.xml EX-101.PRE 22357
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3816
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41599 | Film No.: 25769429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)